Cannabinoid tolerance and dependence: a review of studies in laboratory animals.
Level 5 - mechanism / opinion, no new human data
Narrative review of laboratory animal studies
PubMed 15919107 · doi:10.1016/j.pbb.2005.01.028
What was done
This paper reviews laboratory animal research examining the development of tolerance and dependence following chronic exposure to plant-derived, synthetic, or endogenous cannabinoid agonists. It also synthesizes animal evidence regarding whether chronic cannabinoid administration increases vulnerability to other addictive substances, such as morphine.
What was found
The abstract reports no numerical data or quantitative effect sizes. Key qualitative findings synthesized from animal studies include: (1) prolonged exposure to cannabinoid agonists consistently produces tolerance to most pharmacological effects, predominantly via CB1 receptor desensitization and down-regulation; (2) spontaneous withdrawal signs upon cessation are generally absent, likely due to pharmacokinetic persistence, but precipitated withdrawal occurs following CB1 receptor antagonist administration; (3) precipitated withdrawal features somatic signs and molecular alterations similar to, but typically lower in magnitude than, withdrawal from other drugs of abuse; and (4) cannabinoid-tolerant animals do not exhibit increased vulnerability to the reinforcing properties of morphine.
Why it matters
The review clarifies the neurobiological mechanisms underlying cannabinoid tolerance and physical dependence in preclinical models, delineating pharmacodynamic receptor downregulation from overt spontaneous withdrawal.
Limits
The review relies entirely on non-human animal models, limiting direct translation to human cannabis use disorders. No quantitative meta-analyses, sample sizes, or systematic study selection criteria are reported in the abstract.
Cited by
- contradicts When a drug is introduced to the body, the brain responds by upregulating the receptors for that drug.